Zoltan Pos

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. pmc Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology
    Hideaki Tahara
    Department of Surgery and Bioengineering, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan
    J Transl Med 7:45. 2009
  2. pmc Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy
    Andrea Worschech
    Genelux Corporation, San Diego Science Center, San Diego, California, USA
    BMC Genomics 10:301. 2009
  3. pmc Genomic scale analysis of racial impact on response to IFN-alpha
    Zoltan Pos
    Infectious Disease and Immunogenetics Section, Department of Transfusion Medicine, Clinical Center, and Center for Human Immunology, National Institutes of Health, Bethesda, MD 20892, USA
    Proc Natl Acad Sci U S A 107:803-8. 2010
  4. pmc Serum vascular endothelial growth factor and fibronectin predict clinical response to high-dose interleukin-2 therapy
    Marianna Sabatino
    Infectious Disease and Immunogenetics Section, Department of Transfusion Medicine, Warren G Magnuson Clinical Center, NIH, Bethesda, MD, USA
    J Clin Oncol 27:2645-52. 2009
  5. pmc Antitumor vaccines, immunotherapy and the immunological constant of rejection
    Ena Wang
    National Institutes of Health, Department of Transfusion Medicine, Building 10, Room 1C711, Clinical Center, Bethesda, MD 20892, USA
    IDrugs 12:297-301. 2009
  6. pmc The stable traits of melanoma genetics: an alternate approach to target discovery
    Tara L Spivey
    Infectious Disease and Immunogenetics Section IDIS, Department of Transfusion Medicine, Clinical Center and trans NIH Center for Human Immunology CHI, National Institutes of Health, Bethesda, MD 20892, USA
    BMC Genomics 13:156. 2012
  7. pmc Molecular immune signatures of HIV-1 vaccines in human PBMCs
    Alessandro Monaco
    Infectious Disease and Immunogenetics Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health Bethesda, MD, USA
    FEBS Lett 583:3004-8. 2009
  8. pmc GM-CSF/IL-3/IL-5 receptor common beta chain (CD131) expression as a biomarker of antigen-stimulated CD8+ T cells
    Silvia Selleri
    Infectious Disease and Immunogenetics Section IDIS, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, USA
    J Transl Med 6:17. 2008
  9. pmc Repression of the DNA-binding inhibitor Id3 by Blimp-1 limits the formation of memory CD8+ T cells
    Yun Ji
    Center for Cancer Research, National Cancer Institute, US National Institutes of Health, Bethesda, Maryland, USA
    Nat Immunol 12:1230-7. 2011
  10. pmc Permissivity of the NCI-60 cancer cell lines to oncolytic Vaccinia Virus GLV-1h68
    Maria Libera Ascierto
    Infectious Disease and Immunogenetics Section, Department of Transfusion Medicine, Clinical Center and trans NIH Center of Human Immunology, National Institutes of Health, Bethesda, MD, USA
    BMC Cancer 11:451. 2011

Collaborators

Detail Information

Publications12

  1. pmc Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology
    Hideaki Tahara
    Department of Surgery and Bioengineering, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan
    J Transl Med 7:45. 2009
    ..The institution of an interactive consortium for high throughput molecular monitoring of clinical trials with voluntary participation might provide cost-effective solutions...
  2. pmc Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy
    Andrea Worschech
    Genelux Corporation, San Diego Science Center, San Diego, California, USA
    BMC Genomics 10:301. 2009
    ..GLV-1h68 is an attenuated recombinant vaccinia virus (VACV) that selectively colonizes established human xenografts inducing their complete regression...
  3. pmc Genomic scale analysis of racial impact on response to IFN-alpha
    Zoltan Pos
    Infectious Disease and Immunogenetics Section, Department of Transfusion Medicine, Clinical Center, and Center for Human Immunology, National Institutes of Health, Bethesda, MD 20892, USA
    Proc Natl Acad Sci U S A 107:803-8. 2010
    ....
  4. pmc Serum vascular endothelial growth factor and fibronectin predict clinical response to high-dose interleukin-2 therapy
    Marianna Sabatino
    Infectious Disease and Immunogenetics Section, Department of Transfusion Medicine, Warren G Magnuson Clinical Center, NIH, Bethesda, MD, USA
    J Clin Oncol 27:2645-52. 2009
    ..High-dose interleukin-2 (IL-2) induces durable therapeutic responses in a small subset of patients with metastatic melanoma and renal cell carcinoma, but simple pretreatment predictors of response have not been identified...
  5. pmc Antitumor vaccines, immunotherapy and the immunological constant of rejection
    Ena Wang
    National Institutes of Health, Department of Transfusion Medicine, Building 10, Room 1C711, Clinical Center, Bethesda, MD 20892, USA
    IDrugs 12:297-301. 2009
    ....
  6. pmc The stable traits of melanoma genetics: an alternate approach to target discovery
    Tara L Spivey
    Infectious Disease and Immunogenetics Section IDIS, Department of Transfusion Medicine, Clinical Center and trans NIH Center for Human Immunology CHI, National Institutes of Health, Bethesda, MD 20892, USA
    BMC Genomics 13:156. 2012
    ..We hypothesized that genes steadily expressed by 15 melanoma cell lines (CMs) and their parental tissues (TMs) should be critical for oncogenesis and their expression most frequently influenced by their respective copy number...
  7. pmc Molecular immune signatures of HIV-1 vaccines in human PBMCs
    Alessandro Monaco
    Infectious Disease and Immunogenetics Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health Bethesda, MD, USA
    FEBS Lett 583:3004-8. 2009
    ..This ex vivo screening strategy represents an efficient tool for guiding modifications/optimizations of vaccination strategies and understanding failures in individuals enrolled in clinical trials...
  8. pmc GM-CSF/IL-3/IL-5 receptor common beta chain (CD131) expression as a biomarker of antigen-stimulated CD8+ T cells
    Silvia Selleri
    Infectious Disease and Immunogenetics Section IDIS, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, USA
    J Transl Med 6:17. 2008
    ..Whether this secretion affects in an autocrine loop the CTLs themselves is unknown...
  9. pmc Repression of the DNA-binding inhibitor Id3 by Blimp-1 limits the formation of memory CD8+ T cells
    Yun Ji
    Center for Cancer Research, National Cancer Institute, US National Institutes of Health, Bethesda, Maryland, USA
    Nat Immunol 12:1230-7. 2011
    ..Our findings identify the Blimp-1-Id3-E2A axis as a key molecular switch that determines whether effector CD8(+) T cells are programmed to die or enter the memory pool...
  10. pmc Permissivity of the NCI-60 cancer cell lines to oncolytic Vaccinia Virus GLV-1h68
    Maria Libera Ascierto
    Infectious Disease and Immunogenetics Section, Department of Transfusion Medicine, Clinical Center and trans NIH Center of Human Immunology, National Institutes of Health, Bethesda, MD, USA
    BMC Cancer 11:451. 2011
    ....
  11. ncbi request reprint Spontaneous and treatment-induced cancer rejection in humans
    Ena Wang
    National Institutes of Health, Infectious Disease and Immunogenetics Section, Department of Transfusion Medicine, Clinical Center, Bethesda, Maryland, 20892, USA
    Expert Opin Biol Ther 8:337-49. 2008
    ..On the other hand, it is also well documented that on rare occasions tumors can be dramatically destroyed by the host's immune response...
  12. pmc A human memory T cell subset with stem cell-like properties
    Luca Gattinoni
    Center for Cancer Research, National Cancer Institute, US National Institutes of Health NIH, Bethesda, Maryland, USA
    Nat Med 17:1290-7. 2011
    ..The identification of a human stem cell-like memory T cell population is of direct relevance to the design of vaccines and T cell therapies...